glp-1 advertising crackdown news FEDS CRACK DOWN ON TELEHEALTH COMPANIES SELLING GLP-1s: The U.S. Food and Drug Administration is cracking down on telehealth companies for making “false and misleading” claims about compounded versions of popular weight Ozempic, weight-loss drugs target body

During this time, the body adapts to the medication, eating patterns begin to shift, and measurable changes in weight typically occur

Some patients in our practice have safely achieved a weight loss of up to 40% of their starting weight within 10 months with consistent effort and adherence to recommendations.

If approved, your prescription gets sent to a partner compounding pharmacy

Repeated administration of any synthetic peptide can provoke antibody formation, and the chronic dosing schedules sold by clinics have not been characterised in humans for this molecule [9]

Lets maximize existing, lifesaving and transformative medicines for people with addiction while also exploring innovative therapeutic options like GLP-1 receptor agonists.